2022. Motif prediction of abemaciclib in a breast cancer cell line using ChIP-Seq data analysis. Biomedical Research and Therapy. 9, 3 (Mar. 2022), 4971–4985. DOI:https://doi.org/10.15419/bmrat.v9i3.732.